1. Home
  2. CTW vs BDSX Comparison

CTW vs BDSX Comparison

Compare CTW & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CTW Cayman Class A Ordinary Shares

CTW

CTW Cayman Class A Ordinary Shares

HOLD

Current Price

$2.24

Market Cap

162.2M

Sector

Technology

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$22.84

Market Cap

153.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTW
BDSX
Founded
2013
2005
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.2M
153.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CTW
BDSX
Price
$2.24
$22.84
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
22.4K
67.4K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
N/A
$19.15
P/E Ratio
$22.41
N/A
Revenue Growth
N/A
24.08
52 Week Low
$1.10
$0.33
52 Week High
$3.14
$24.92

Technical Indicators

Market Signals
Indicator
CTW
BDSX
Relative Strength Index (RSI) N/A 60.22
Support Level N/A $19.00
Resistance Level N/A $24.92
Average True Range (ATR) 0.00 1.72
MACD 0.00 -0.10
Stochastic Oscillator 0.00 65.36

Price Performance

Historical Comparison
CTW
BDSX

About CTW CTW Cayman Class A Ordinary Shares

CTW operates as a gaming platform company providing instant access to free-to-play, browser-based games inspired by popular Japanese animation, including "So I'm a Spider, So What? Ruler of the Labyrinth, Arifureta: From Commonplace to World's Strongest - Rebellion Soul", and "Queen's Blade Limit Break". CTW delivers these games through its flagship HTML5 platform, G123.jp.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: